跳至主要内容
临床试验/NCT03305536
NCT03305536Unknown2 期

Decalcification of the Aortic Valve by Vitamin K2 (Menaquinone-7)

Hopital St. Georges, Ajaltoun1 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2018年1月2日最近更新:
适应症
干预措施

试验速览

阶段
2 期
发起方
入组人数
150
试验地点
1
主要终点
Evolution of the Aortic Valve Hemodynamic measured by echography: Change in Surface area in (cm2/m2)

研究概览

简要总结

Aortic Stenosis is a common but fatal disease when it becomes symptomatic, specially if not treated. Until now surgery remains the only reliable and effective treatment.

In this study, the investigators will examine the effect of high dose of Menaquinone-7 (MK-7) supplementation (1000 mcg)/day on the progression of the aortic valve disease. The investigators hypothesize that MK-7 supplementation may slow or even reverse the progression of the disease process.

详细描述

The study is a randomized clinical trial that will use Cardiac Echography and multi-detector computed tomography to compare the changes in the Aortic Valve Calcification Score (AVCS) over 3 years when using:

  1. 1000 mcg/d Vitamin K2 (menaquinone-7) + 5000 IU/d Vitamin D3
  2. 5000 IU/d Vitamin D3 as a control group

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
30 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • AVCS > 300 without aortic valve stenosis requiring operation
  • Focus on patients with:
  • Bicuspid aortic valve
  • Dialysis or CKD
  • Statin treatment

排除标准

  • Use of Vitamin K antagonist
  • Malabsorption Problem
  • LVEF < 40%
  • A life expectancy < 3 years

研究组 & 干预措施

Interventional

Active Comparator

1000 mcg/day of Vitamin K2 + 5000 IU/day Vitamin D3 as a treatment to decalcifiy the valve

干预措施: Vitamin K2 (Menaquinone 7) + Vitamin D3 (Dietary Supplement)

interventional

Active Comparator

5000 IU/day of Vitamin D3 will be given to measure the progression of the disease along the time of the study

干预措施: Vitamin K2 (Menaquinone 7) + Vitamin D3 (Dietary Supplement)

结局指标

主要结局

Evolution of the Aortic Valve Hemodynamic measured by echography: Change in Surface area in (cm2/m2)

时间窗: 3 years

Evolution of the Aortic Valve Hemodynamic measured by echography: Change in V max in (m/sec)

时间窗: 3 years

Evolution of the Aortic Valve Hemodynamic measured by echography: Change in Gradients in (mm Hg)

时间窗: 3 years

次要结局

  • Activation of the MGP measured by the dp-uc MGP level which is a marker of vascular calcification.(3 years)
  • Improvement of the quality of life of the patients(3 years)
  • Improvement of dyspnea (at rest and effort)(3 years)
  • Reduction of the Aortic Valve calcification measured by CT Scan(3 years)

研究者

发起方
Hopital St. Georges, Ajaltoun
申办方类型
Other
责任方
Principal Investigator
主要研究者

Rodolph Frangi

Head of Department of Thoracic and Cardiovascular surgery

Hopital St. Georges, Ajaltoun

研究点 (1)

Loading locations...

相似试验